Horses diagnosed with pituitary pars intermedia dysfunction do not have shorter life expectancies but experience more medical events during their lifetime.

Research Overview

• This study examined whether horses diagnosed with pituitary pars intermedia dysfunction (PPID) have different life expectancies and experience more medical problems compared to horses without PPID.
• The findings reveal that horses with PPID do not have a shorter lifespan but do suffer from more medical issues during their lives.

Study Purpose and Hypothesis

• Investigate the frequency of comorbidities (additional medical conditions) in horses diagnosed with PPID in general veterinary practice (“first-opinion” practice).
• Test the hypothesis that horses with PPID would:
  • Experience more frequent medical events (health problems).
  • Be euthanized at a younger age compared to similar horses without PPID.

Study Design and Methods

• A retrospective case-control study design was used, analyzing medical records from 1996 to 2024.
• Sample included 132 horses diagnosed with PPID and 274 control horses matched by age and breed to ensure comparability.
• Statistical analyses comprised:
  • Fisher exact test and Mann-Whitney U test to look for associations between variables and PPID diagnosis.
  • Conditional logistic regression to identify factors independently associated with PPID.
• Results were reported using median values with interquartile ranges (IQR) and as percentages of the total sample.

Key Findings

• Life Expectancy:
  • Horses with PPID had a median age at euthanasia of 26 years (IQR 22 to 31 years).
  • Control horses had a median euthanasia age of 24 years (IQR 21 to 29 years).
  • No statistically significant difference was found, indicating PPID does not shorten life expectancy.
• Medical Events and Comorbidities Associated with PPID:
  • Poor wound healing was more common in PPID horses.
  • Dental problems, including missing teeth and the condition known as equine odontoclastic tooth resorption and hypercementosis, were linked with PPID.
  • Hyperinsulinemia-associated laminitis (a painful hoof disease related to insulin dysregulation) was frequently observed in the PPID group.
  • Horses with PPID were more often prescribed non-steroidal anti-inflammatory drugs (NSAIDs), reflecting a higher occurrence of painful or inflammatory conditions.

Conclusions and Implications

• Although PPID does not reduce overall life expectancy, it is associated with a greater burden of medical conditions over the horse’s lifetime.
• Veterinarians and horse owners should be aware that horses with PPID tend to experience more health issues such as poor healing and metabolic disorders like laminitis.
• Management of PPID should include close monitoring and treatment of comorbidities to maintain quality of life.